KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Quest Diagnostics (DGX) Cost of Revenue: 2009-2024

Historic Cost of Revenue for Quest Diagnostics (DGX) over the last 16 years, with Dec 2024 value amounting to $6.6 billion.

  • Quest Diagnostics' Cost of Revenue rose 11.33% to $1.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $7.2 billion, marking a year-over-year increase of 12.78%. This contributed to the annual value of $6.6 billion for FY2024, which is 6.92% up from last year.
  • Latest data reveals that Quest Diagnostics reported Cost of Revenue of $6.6 billion as of FY2024, which was up 6.92% from $6.2 billion recorded in FY2023.
  • Over the past 5 years, Quest Diagnostics' Cost of Revenue peaked at $6.6 billion during FY2024, and registered a low of $5.8 billion during FY2020.
  • Moreover, its 3-year median value for Cost of Revenue was $6.5 billion (2022), whereas its average is $6.4 billion.
  • Per our database at Business Quant, Quest Diagnostics' Cost of Revenue climbed by 15.23% in 2020 and then dropped by 3.89% in 2023.
  • Yearly analysis of 5 years shows Quest Diagnostics' Cost of Revenue stood at $5.8 billion in 2020, then climbed by 13.35% to $6.6 billion in 2021, then declined by 1.96% to $6.5 billion in 2022, then decreased by 3.89% to $6.2 billion in 2023, then increased by 6.92% to $6.6 billion in 2024.